Skip to content

New Feature: Text Message Treatment Updates

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated texts with the intention of collecting data on their medical cannabis treatment outcomes.

How It Works

When creating a new patient case, physicians input the patient’s phone number along with all other relevant information. Once a phone number is entered, a drop-down box will appear offering the physician to choose if the patient has opted in for text message updates. These text message updates will automatically be sent to the patient at a specific date and time with a request to rate their treatment efficacy on a scale of one (Adverse Reaction) to five (Total Resolution of Symptoms). All the patient will then have to do is respond with a number (1 through 5), and the data is collected in their case file.

The Benefit

“We want to ensure that physicians have real-time responses from their patients about their medical cannabis treatment plans,” said James West, founder and CEO of Arfinn Med. “Several states have long durations between required appointments, so physicians need to have tools to track their patients’ progress and create an open dialogue during a treatment period to increase the likelihood that the treatment plan will be further customized for the patient.”

Providing this type of feature will significantly save physicians time when collecting updates from patients. Instead of lengthy office visits or following up via phone call, one text can collect all the information needed. All data received through this text messaging feature is a real time update to help give a full picture of how that specific treatment is affecting each patient. Along with saving both the physician and patient time, this feature is also expected to increase patient retention. With such a hands-on approach, the text messaging feature will encourage patients to keep their physicians updated and refine the treatment plan, if/as needed, to obtain the results they desire.


At Arfinn Med, we are dedicated to helping medical professionals and their patients combat debilitating diseases and conditions with the use of medical marijuana. By relying on actual physician observations regarding patient outcomes, doctors can create reports based on the effectiveness, daily dosage and delivery mode of cannabis treatments specific to various patient demographics. Are you ready to join a nationwide network of medical professionals to learn more about medical marijuana and what it can do for your patients? Join Arfinn Med for FREE today!

Stories you may be interested in

Texas House Bill 3703: What You Need to Know

The state of Texas has been in the news in recent months as the legislature review House Bill 3703. This bill relates to “the prescription of low-THC cannabis for medical use by certain qualified physicians to patients with [specific] qualifying conditions”. Originally filed in March of 2019, this bill made its way through the house…
Read More

Norfolk research company plans clinical trials using medical marijuana

Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More

Medical marijuana helped elderly with chronic pain and reduced their use of opioids, study found

Your grandparents’ chronic aches and pains might best be eased with a little weed, a new study suggests. Not only did folks over 75 who took medical marijuana report less pain, their use of pot-based capsules, tinctures and e-cigarettes allowed a third of these patients to reduce their use of opioid painkillers, researchers found. “Medical marijuana, in…
Read More

Customize Your Patient Notes with Arfinn Med

Joining the text messaging update, the Arfinn Med portal now presents the ability to create note taking templates. This innovative addition will allow physicians to streamline the data and information that they are collecting from patients, resulting in their cases staying aligned and concise. Additionally, through this function, physicians will be able to pick and…
Read More

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More